OVERVIEW
A recent report by the Global Market Studies has estimated the growth of the NGS Sample Preparation Market to USD 4.1 billion by 2028, growing at a CAGR of approximately 13%. The outbreak of the COVID-19 pandemic led to the need to develop effective and quick sequencing methods. NGS sample preparation emerged as a more efficient technology, swiftly replacing PCR and now has a wide range of applications in virology – the detection of novel viruses from metagenomic samples, reconstruction of whole or almost complete viral genome sequences, and viral evolution and subspecies analysis.
The NGS Sample Preparation Market refers to a massively parallel sequencing technology that offers ultra-high throughput, scalability, and speed. The technology is used to determine the order of nucleotides in entire genomes or targeted regions of DNA or RNA.
TABLE OF CONTENT
1 Global NGS Sample Preparation Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global NGS Sample Preparation Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global NGS Sample Preparation Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global NGS Sample Preparation Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global NGS Sample Preparation Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global NGS Sample Preparation Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global NGS Sample Preparation Market – By Product (Market Size – & million/billion)
8.1 Workstations
8.2 Reagents & Consumables
9 Global NGS Sample Preparation Market – By Workflow
9.1 DNA
9.2 Target Enrichment
9.3 RNA
9.4 Quality Control
10 Global NGS Sample Preparation Market – By Technology
10.1 Sequencing by Synthesis (SBS)
10.2 Ion Semiconductor Sequencing
10.3 Single-molecule Real-time (SMRT) Sequencing
10.4 Nanopore Sequencing
10.5 Other
11 Global NGS Sample Preparation Market – By Application
11.1 Disease Diagnostics
11.2 Drug Discovery
11.3 Agricultural and Animal Research
11.4 Other
12 Global NGS Sample Preparation Market – By End-User
12.1 Academic Institutes and Research Centers
12.2 Hospitals & Clinics
12.3 Pharmaceutical & Biotechnology Companies
12.4 Other
13 Global NGS Sample Preparation Market – By Geography (Market Size – & million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa
14 Global NGS Sample Preparation Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships
15 Global NGS Sample Preparation Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Becton, Dickinson and Company
15.3 Beckman Coulter (A Subsidiary of Danaher)
15.4 F. Hoffmann-La Roche AG
15.5 Illumina, Inc.
15.6 Agilent Technologies, Inc.
15.7 Oxford Gene Technology (Part of Sysmex)
15.8 Oxford Nanopore Technologies, Ltd.
15.9 Pacific Biosciences of California, Inc.
15.10 New England Biolabs, Inc.
15.11 Nugen Technologies, Inc. (Part of Tecan Trading Ag)
15.12 Company 11 & more
16 Global NGS Sample Preparation Market – Appendix
16.1 Sources
16.2 Abbreviations
